Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy.
Kazuma FujitaSatoru MotoyamaYusuke SatoAkiyuki WakitaYushi NagakiYoshihiro MinamiyaMasatomo MiuraPublished in: Esophagus : official journal of the Japan Esophageal Society (2021)
We determined that ABCC2 -24C>T is significantly associated with grade 3-4 hematological toxicity after platinum plus 5-FU therapy. These findings might contribute to improved treatment strategies for patients with esophageal cancer.